carteolol and dinoprost

carteolol has been researched along with dinoprost in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amano, S; Inoue, K; Inoue, Y; Kato, S; Okugawa, K; Oshika, T; Tomita, G1
Dorigo, MT; Dorigo, P; Floreani, M; Quintieri, L; Varani, K1

Other Studies

2 other study(ies) available for carteolol and dinoprost

ArticleYear
Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.
    Journal of glaucoma, 2003, Volume: 12, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Carteolol; Dinoprost; Drug Therapy, Combination; Epithelium, Corneal; Female; Glaucoma, Open-Angle; Humans; Keratitis; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Risk Factors; Sulfonamides; Tears; Thiophenes; Timolol

2003
Carteolol, a non-conventional partial agonist of beta(1)-adrenoceptors, relaxes phenylephrine-constricted rat aorta through antagonism at alpha(1)-adrenoceptors.
    European journal of pharmacology, 2008, Aug-20, Volume: 590, Issue:1-3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Animals; Aorta; Carteolol; Dinoprost; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Male; Phenylephrine; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Vasodilation

2008